Confirmation of non-inferiority compared to existing treatments…To be discussed with global health authorities [의약뉴스] GSK has proven the effectiveness of its oral antibiotic candidate gepotidacin in a phase 3 clinical trial for gonorrhea. GSK announced positive headline results from EAGLE-1, a pivotal Phase 3 clinical trial evaluating gepotidacin, a first-in-class oral antibiotic with a novel … Continue reading GSK’s Gepotidacin Proven Effective in Phase 3 Clinical Trial for Gonorrhea: Non-Inferiority Confirmed, to be Discussed with Global Health Authorities